FDA Inspection 1001761 — AdventHealth, Daytona Beach
The FDA completed an inspection of AdventHealth, Daytona Beach on Jan 12, 2017 in Daytona Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Daytona Beach, FL (United States)